![cover image](https://wikiwandv2-19431.kxcdn.com/_next/image?url=https://upload.wikimedia.org/wikipedia/commons/thumb/b/bb/Doxifluridine.svg/640px-Doxifluridine.svg.png&w=640&q=50)
Doxifluridine
Nucleoside analog prodrug / From Wikipedia, the free encyclopedia
Doxifluridine (5'-deoxy-5-fluorouridine) is a second generation nucleoside analog prodrug developed by Roche and used as a cytostatic agent in chemotherapy in several Asian countries including China and South Korea.[1] Doxifluridine is not FDA-approved for use in the USA. It is currently being evaluated in several clinical trials as a stand-alone or combination therapy treatment.
Quick Facts Clinical data, Other names ...
![]() | |
Clinical data | |
---|---|
Other names | Doxyfluridine; doxifluridine; 5'-deoxy-5-fluorouridine; 5'-deoxy-5'-fluorouridine; 5'-fluoro-5'-deoxyuridine; 5'-dFUrd; 5'-DFUR; Furtulon; Ro 21-9738 |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.019.491 ![]() |
Chemical and physical data | |
Formula | C9H11FN2O5 |
Molar mass | 246.194 g·mol−1 |
3D model (JSmol) | |
| |
|
Close